Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

Read full text Summarise with VIRAT
Authors: Lina Schiffer, Amarah V. Anthony, Laura B. L. Wittemans, AE Taylor, Imken Oestlund, Antonio M. A. Miranda, Eka Melson, Tara McDonnell, Punith Kempegowda, Paul Smith, T. Justin Clark, Martin Wabitsch
+9 more Michael O’Reilly, Michaele Peters, Andrea Wagenfeld, Jan-Peter Ingwersen, Jacky L. Snoep, William R. Scott, Jan Hilpert, Karl‐Heinz Storbeck, Wiebke Arlt
Cited by: 0
References: 44

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Androgen excess drives metabolic and reproductive complications in polycystic ovary syndrome (PCOS), affecting 10-15% of women globally. Aldo-keto reductase 1C3 (AKR1C3) converts inactive precursors from both the classic and the recently identified 11-oxygenated androgen pathways, generating testosterone and 11-ketotestosterone, respectively, which exert comparable androgen receptor activation. Both circulate in similar concentrations in premenopausal women while 11-ketotestosterone is predominant after menopause and in PCOS. Here, we show that adipocytes are a major site of AKR1C3 and androgen receptor expression, with increased expression in women and individuals with obesity. Using human female adipose tissue explants, we find a much higher activation of 11-oxygenated over classic androgens, observing a decrease in 11-oxygenated but not classic androgen activation by AKR1C3 inhibition. Correspondingly, we demonstrate that AKR1C3 inhibitor treatment in premenopausal women selectively disrupts the activation of 11-oxygenated androgens. Pharmacological targeting of AKR1C3 provides a novel strategy to alleviate systemic and intra-adipose 11-oxygenated androgen excess. One Sentence Summary Inhibition of the androgen-activating enzyme AKR1C3 results in a major decrease in 11-oxygenated but not classic androgens in women.

Fields of Study & Subjects

Ovarian function and disorders Aldose Reductase and Taurine Hormonal and reproductive studies

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publication date
30 March 2026
Language
EN
Document type
Preprint